Identification of proteins in human substantia nigra

Proteomics - Clinical Applications

Volumn 2, Issue 5, 2008, Pages 776-782

  Kitsou, Efstathia ^a   Pan, Sheng ^a   Zhang, Jian Peng ^a   Shi, Min ^a   Zabeti, Aram ^a   Dickson, Dennis W ^b   Albin, Roger ^c   Gearing, Maria ^d   Kashima, Daniel T ^a   Wang, Yan ^a   Beyer, Richard P ^e   Zhou, Yong ^f   Pan, Catherine ^a   Caudle, W Michael ^a   Zhang, Jing ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

Biomarkers; Cerebrospinal fluid; MS; Parkinson's disease; Substantia nigra pars compacta

Indexed keywords

BIOLOGICAL MARKER; CALBINDIN; CALMODULIN; COFILIN; GAMMA SYNUCLEIN; PROTEIN 14 3 3; STATHMIN;

AGED; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUBSTANTIA NIGRA;

EID: 44649194448     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800028     Document Type: Article

References (53)

1. Pan, S., Shi, M., Jin, J., Albin, R. L. et al., Proteomics identification of proteins in human cortex using multi-dimensional separations and MALDI tandem mass spectrometer. Mol. Cell. Proteomics 2007, 6, 1818-1823.
2. Pan, S., Zhu, D., Quinn, J. F., Peskind, E. R. et al., A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry. Proteomics 2007, 7, 469-473.
3. Jin, J., Meredith, G. E., Chen, L., Zhou, Y. et al., Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease. Brain Res. Mol. Brain Res. 2005, 134, 119-138.
4. He, S., Wang, Q., He, J., Pu, H. et al., Proteomic analysis and comparison of the biopsy and autopsy specimen of human brain temporal lobe. Proteomics 2006, 6, 4987-4996.
5. Dumont, D., Noben, J. P., Verhaert, P., Stinissen, R, Robben, J., Gel-free analysis of the human brain proteome: Application of liquid chromatography and mass spectrometry on biopsy and autopsy samples. Proteomics 2006, 6, 4967-4977.
6. Ehringer, H., Hornykiewicz, O., Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Klin. Wochenschr. 1960, 38, 1236-1239.
7. Jin, J., Hulette, C., Wang, Y., Zhang, T. et al., Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: Relevance to Parkinson disease. Mol. Cell. Proteomics 2006, 5, 1193-1204.
8. Basso, M., Giraudo, S., Corpillo, D., Bergamasco, B. et al., Proteome analysis of human substantia nigra in Parkinson's disease. Proteomics 2004, 4, 3943-3952.
9. Mirra, S. S., The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: A commentary. Neurobiol. Aging 1997, 18, S91-S94.
10. McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K. et al., Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996, 47, 1113-1124.
11. Abdi, F., Quinn, J. F., Jankovic, J., Mcintosh, M. et al., Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J. Alzheimers Dis. 2006, 9, 293-348.
12. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F. et al., Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 1999, 17, 994-999.
13. Zhang, J., Goodlett, D. R., Peskind, E. R., Quinn, J. F. et al., Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid. Neurobiol. Aging 2005, 26, 207-227.
14. Chelius, D., Zhang, T., Wang, G., Shen, R. F., Global protein identification and quantification technology using two-dimensional liquid chromatography nanospray mass spectrometry. Anal. Chem. 2003, 75, 6658-6665.
15. Keller, A., Nesvizhskii, A. I., Kolker, E., Aebersold, R., Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74, 5383-5392.
16. Jin, J., Li, G. J., Davis, J., Zhu, D. et al., Identification of novel proteins associated with both alpha-synuclein and DJ-1. Mol. Cell. Proteomics 2007, 6, 845-859.
17. Camon, E., Magrane, M., Barrell, D., Lee, V. et al., The gene ontology annotation (GOA) database: Sharing knowledge in Uniprot with Gene Ontology. Nucleic Acids Res. 2004, 32, D262-D266.
18. Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B. et al., Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5, R80.
19. Durinck, S., Moreau, Y., Kasprzyk, A., Davis, S. et al., BioMart and bioconductor: A powerful link between biological databases and microarray data analysis. Bioinformatics 2005, 21, 3439-3440.
20. Washburn, M. P., Wolters, D., Yates, J. R., 3rd Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 2001, 19, 242-247.
21. Xu, J., Chen, J., Peskind, E. R., Jin, J. et al., Characterization of proteome of human cerebrospinal fluid. Int. Rev. Neurobiol. 2006, 73, 29-98.
22. Park, Y. M., Kim, J. Y., Kwon, K. H., Lee, S. K. et al., Profiling human brain proteome by multi-dimensional separations coupled with MS. Proteomics 2006, 6, 4978-4986.
23. Pavlidis, P., Noble, W. S., Analysis of strain and regional variation in gene expression in mouse brain. Genome Biol. 2001, 2, RESEARCH0042.
24. Persechini, A., Moncrief, N. D., Kretsinger, R. H., The EF-hand family of calcium-modulated proteins. Trends Neurosci. 1989, 12, 462-467.
25. Baimbridge, K. G., Celio, M. R., Rogers, J. H., Calcium-binding proteins in the nervous system. Trends Neurosci. 1992, 15, 303-308.
26. Haber, S. N., Ryoo, H., Cox, C., Lu, W., Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity. J. Comp. Neurol. 1995, 362, 400-410.
27. Gerfen, C. R., Baimbridge, K. G., Miller, J. J., The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey. Proc. Natl. Acad. Sci. USA 1985, 82, 8780-8784.
28. Thompson, L., Barraud, P., Andersson, E., Kirik, D., Bjorklund, A., Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. J. Neurosci. 2005, 25, 6467-6477.
29. Damier, P., Hirsch, E. C., Agid, Y., Graybiel, A. M., The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain 1999, 122, 1421-136.
30. Airaksinen, M. S., Thoenen, H., Meyer, M., Vulnerability of midbrain dopaminergic neurons in calbindin-D28k-deficient mice: lack of evidence for a neuroprotective role of endogenous calbindin in MPTP-treated and weaver mice. Eur. J. Neurosci. 1997, 9, 120-127.
31. Martinez, J., Moeller, I., Erdjument-Bromage, H., Tempst, P., Lauring, B., Parkinson's disease-associated alpha-synuclein is a calmodulin substrate. J. Biol. Chem. 2003, 278, 17379-17387.
32. Lee, C. S., Han, E. S., Han, Y. S., Bang, H., Differential effect of calmodulin antagonists on MG132-induced mitochondrial dysfunction and cell death in PC12 cells. Brain Res. Bull. 2005, 67, 225-234.
33. Pierson, J., Norris, J. L., Aerni, H. R., Svenningsson, P. et al., Molecular profiling of experimental Parkinson's disease: direct analysis of peptides and proteins on brain tissue sections by MALDI mass spectrometry. J. Proteome Res. 2004, 3, 289-295.
34. Bamburg, J. R., Proteins of the ADF/cofilin family: essential regulators of actin dynamics. Annu. Rev. Cell Dev. Biol. 1999, 15, 185-230.
35. Kiuchi, T., Ohashi, K., Kurita, S., Mizuno, K., Cofilin promotes stimulus-induced lamellipodium formation by generating an abundant supply of actin monomers. J. Cell Biol. 2007, 177, 465-476.
36. Heredia, L., Helguera, P., de Olmos, S., Kedikian, G. et al., Phosphorylation of actin-depolymerizing factor/cofilin by LIM-kinase mediates amyloid beta-induced degeneration: a potential mechanism of neuronal dystrophy in Alzheimer's disease. J. Neurosci. 2006, 26, 6533-6542.
37. Minamide, L. S., Striegl, A. M., Boyle, J. A., Meberg, P. J., Bamburg, J. R., Neurodegenerative stimuli induce persistent ADF/cofilin-actin rods that disrupt distal neurite function. Nat. Cell Biol. 2000, 2, 628-636.
38. Cuadrado-Tejedor, M., Sesma, M. T., Gimenez-Amaya, J. M., Ortiz, L., Changes in cytoskeletal gene expression linked to MPTP-treatment in Mice. Neurobiol. Dis. 2005, 20, 666-672.
39. Lim, M. K., Kawamura, T., Ohsawa, Y., Ohtsubo, M. et al., Parkin interacts with LIM Kinase 1 and reduces its cofilin-phosphorylation activity via ubiquitination. Exp. Cell Res. 2007, 313, 2858-2874.
40. Xu, J., Kao, S. Y., Lee, F. J., Song, W. et al., Dopamine-dependant neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat. Med. 2002, 8, 600-606.
41. Kawamoto, Y., Akiguchi, I., Nakamura, S., Honjyo, Y. et al., 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains. J. Neuropathol. Exp. Neurol. 2002, 61, 245-253.
42. Sato, S., Chiba, T., Sakata, E., Kato, K. et al., 14-3-3eta is a novel regulator of parkin ubiquitin ligase. EMBO J. 2006, 25, 211-221.
43. Jin, K., Mao, X. O., Cottrell, B., Schilling, B. et al., Proteomic and immunochemical characterization of a role for stathmin in adult neurogenesis. FASEB J. 2004, 18, 287-299.
44. Gavet, O., Ozon, S., Manceau, V., Lawler, S. et al., The stathmin phosphoprotein family: intracellular localization and effects on the microtubule network. J. Cell Sci. 1998, 111, 3333-3346.
45. Strey, C. W., Spellman, D., Stieber, A., Gonatas, J. O. et al., Dysregulation of stathmin, a microtubule-destabilizing protein, and up-regulation of Hsp25, Hsp27, and the antioxidant peroxiredoxin 6 in a mouse model of familial amyotrophic lateral sclerosis. Am. J. Pathol. 2004, 165, 1701-1718.
46. Jin, L. W., Masliah, E., Iimoto, D., Deteresa, R. et al., Neurofibrillary tangle-associated alteration of stathmin in Alzheimer's disease. Neurobiol. Aging 1996, 17, 331-341.
47. Gosavi, N., Lee, H. J., Lee, J. S., Patel, S., Lee, S. J., Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion. J. Biol. Chem. 2002, 277, 48984-48992.
48. Fujita, Y., Ohama, E., Takatama, M., Al-Sarraj, S., Okamoto K., Fragmentation of Golgi apparatus of nigral neurons with alpha-synuclein-positive inclusions in patients with Parkinson's disease. Acta Neuropathol. 2006, 112, 261-265.
49. Goedert, M., Alpha-synuclein and neurodogenerative diseases. Nat. Rev. Neurosci. 2001, 2, 492-501.
50. Lavedan, C., Leroy, E., Dehejia, A., Buchholtz, S. et al., Identification, localization and characterization of the human gamma-synuclein gene. Hum. Genet. 1998, 103, 106-112.
51. Galvin, J. E., Uryu, K., Lee, V. M., Trojanowski, J. Q., Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc. Natl. Acad. Sci. USA 1999, 96, 13450-13455.
52. Uversky, V. N., Li, J., Souillac, P., Millett, I. S. et al., Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta-and gamma-synucleins. J. Biol. Chem. 2002, 277, 11970-11978.
53. Fearnley, J. M., Lees, A. J., Ageing and Parkinson's disease: Substantia nigra regional selectivity. Brain 1991, 114, 2283-2301.